|
||||||||||||||||
|
||||||||||||||||
| HUM-MOLGEN -> mail archive | Search | register for news alert (free) | |||||||||||||||
| Carlo Gambacorti: DIAG: Pelizaeus syndrome | ||||||||||||||||
|
[Author Prev][Author Next][Thread Prev][Thread Next][Author Index][Topic Index] |
||||||||||||||||
|
To: Multiple recipients of list HUM-MOLGEN <HUM-MOLGEN@NIC.SURFNET.NL> Subject: DIAG: Pelizaeus syndrome From: Carlo Gambacorti <GAMBACORTI@icil64.cilea.it> Date: Thu, 14 Dec 1995 09:53:00 MET-DST
**************************************************************
HUM-MOLGEN DIAGnostics/Clinical Research
**************************************************************
This DIAG message contains 1 submessage(s):
1) Pelizaeus-Merzbacher disease
Carlo Gambacorti MD, Editor,
Human Molecular Genetics network
Diagnostics/Clinical Research Section
**************************************************************
**************************************************************
Dear Colleague,
We have identified a pair of brothers with Pelizaeus-Merzbacher
disease. The diagnosis is based on the classical clinical features and
an absence of central myelination in one brother who has died. An MRI of
the surviving brother has not been obtained.
Is anyone interested in obtaining blood or DNA from the surviving boy
for mutation studies of the PLP gene? We would appreciate molecular
analysis to aid genetic counselling.
We would also value comments re the accuracy of MRI for identifying
carriers. We are aware of the paper by Boltshauser et al (Hum Genet
80:393-394, 1988). What has your experience been?
Yours sincerely,
Graeme Suthers
----------------------------------------------------------------------
Dr Graeme Suthers tel (int)-61-8-204 7375
SA Clinical Genetics Service fax (int)-61-8-204 6088
Centre for Medical Genetics gsuthers@medicine.adelaide.edu.au
Women's & Children's Hospital
North Adelaide SA 5006 AUSTRALIA
----------------------------------------------------------------------
|
||||||||||||||||
|
||||||||||||||||
|
Mail converted by |
||||||||||||||||